ITCI logo

Intra-Cellular Therapies (ITCI) Net Income

Annual Net Income

-$74.68 M
+$65.00 M+46.54%

December 31, 2024

Summary

Performance

1-Year Change

+46.54%

3-Year Change

+73.72%

5-Year Change

+49.45%

15-Year Change

+23.62%

ITCI Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.07%
ITCI annual net profit is higher than 27.07% of companies in Healthcare sector

High & Low

All-time High

-$16.59 M

3-Year Low

-$284.13 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ITCI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ITCI next annual earnings announcement has not yet been scheduled

OtherITCIprofitabilitymetrics:

Annual Net Margin

-10.97%
ITCI annual net profit margin is -10.97%

Annual Revenue

$680.50 M
ITCI annual revenue is $680.50 million

Annual Gross Profit

$623.54 M
ITCI annual gross profit is $623.54 million

Annual EPS

-$0.72
ITCI annual earnings per share is -$0.72

Quarterly Net Income

-$16.89 M
+$9.44 M+35.86%

December 1, 2024

Summary

Performance

3-Month Change

+35.86%

1-Year Change

+35.86%

3-Year Change

+30.39%

5-Year Change

+30.39%

ITCI Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.8%
ITCI quarterly net profit is higher than 29.8% of companies in Healthcare sector

High & Low

All-time High

-$10.90 K

3-Year Low

-$86.60 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ITCI previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 7, 2025
ITCI next earnings announcement is scheduled for May 7, 2025

OtherITCIprofitabilitymetrics:

Quarterly Net Margin

-8.48%
ITCI quarterly net profit margin is -8.48%

Quarterly Revenue

$199.22 M
ITCI quarterly revenue is $199.22 million

Quarterly Gross Profit

$178.82 M
ITCI quarterly gross profit is $178.82 million

Quarterly EPS

-$0.16
ITCI quarterly earnings per share is -$0.16

TTM Net Income

-$74.68 M
+$11.69 M+13.54%

December 1, 2024

Summary

Performance

3-Month Change

+13.54%

1-Year Change

+13.54%

3-Year Change

+51.86%

5-Year Change

+51.86%

ITCI TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.33%
ITCI TTM net profit is higher than 27.33% of companies in Healthcare sector

High & Low

All-time High

-$10.90 K

3-Year Low

-$321.36 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ITCI previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 7, 2025
ITCI next earnings announcement is scheduled for May 7, 2025

OtherITCIprofitabilitymetrics:

Annual Net Margin

-10.97%
ITCI annual net profit margin is -10.97%

TTM Revenue

$680.50 M
ITCI TTM revenue is $680.50 million

TTM Gross Profit

$623.54 M
ITCI TTM gross profit is $623.54 million

TTM EPS

-$0.73
ITCI TTM earnings per share is -$0.73

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$74.68 M
ITCI annual net profit is -$74.68 million

Annual Revenue

$680.50 M
ITCI annual revenue is $680.50 million

Annual Cost Of Goods Sold

$56.96 M
ITCI annual cost of goods sold is $56.96 million

Annual Operating Expenses

$740.26 M
ITCI annual total operating expenses is $740.26 million

Annual Interest Expense

-
ITCI annual interest expense value is unknown

Annual Income Tax

$473.00 K
ITCI annual income tax is $473.00 thousand

ITCI Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.5%+35.9%+13.5%
3 y3 years+73.7%+30.4%+51.9%
5 y5 years+49.5%+30.4%+51.9%

ITCI Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+73.7%-10.7%+80.5%at high+76.8%
5 y5-yearat high+73.7%-10.7%+80.5%at high+76.8%
alltimeall time-350.1%+73.7%<-9999.0%+80.5%<-9999.0%+76.8%

Intra-Cellular Therapies Net Income History

DateAnnualQuarterlyTTM
Dec 2024
-$74.68 M(-46.5%)
-
-
Dec 2024
-
-$16.89 M(-35.9%)
-$74.68 M(-13.5%)
Sep 2024
-
-$26.32 M(+62.3%)
-$86.37 M(+2.5%)
Jun 2024
-
-$16.22 M(+6.4%)
-$84.30 M(-24.0%)
Mar 2024
-
-$15.25 M(-46.6%)
-$110.87 M(-20.6%)
Dec 2023
-$139.67 M(-45.5%)
-$28.58 M(+17.8%)
-$139.67 M(-10.0%)
Sep 2023
-
-$24.26 M(-43.3%)
-$155.12 M(-15.9%)
Jun 2023
-
-$42.78 M(-2.9%)
-$184.37 M(-19.2%)
Mar 2023
-
-$44.05 M(+0.1%)
-$228.19 M(-11.0%)
Dec 2022
-$256.26 M(-9.8%)
-$44.03 M(-17.7%)
-$256.26 M(-14.0%)
Sep 2022
-
-$53.51 M(-38.2%)
-$297.96 M(-7.3%)
Jun 2022
-
-$86.60 M(+20.1%)
-$321.36 M(+5.9%)
Mar 2022
-
-$72.12 M(-15.9%)
-$303.50 M(+6.8%)
Dec 2021
-$284.13 M(+25.2%)
-$85.73 M(+11.5%)
-$284.13 M(+9.7%)
Sep 2021
-
-$76.91 M(+11.9%)
-$259.09 M(+9.2%)
Jun 2021
-
-$68.74 M(+30.3%)
-$237.37 M(+2.2%)
Mar 2021
-
-$52.74 M(-13.1%)
-$232.34 M(+2.3%)
Dec 2020
-$227.01 M(+53.7%)
-$60.70 M(+10.0%)
-$227.01 M(+9.7%)
Sep 2020
-
-$55.18 M(-13.4%)
-$206.89 M(+10.9%)
Jun 2020
-
-$63.71 M(+34.4%)
-$186.57 M(+16.4%)
Mar 2020
-
-$47.41 M(+16.8%)
-$160.30 M(+8.5%)
Dec 2019
-$147.72 M
-$40.58 M(+16.4%)
-$147.72 M(-0.1%)
Sep 2019
-
-$34.86 M(-6.9%)
-$147.89 M(-4.3%)
Jun 2019
-
-$37.44 M(+7.5%)
-$154.55 M(+0.0%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$34.84 M(-14.5%)
-$154.48 M(-0.4%)
Dec 2018
-$155.13 M(+58.7%)
-$40.75 M(-1.9%)
-$155.13 M(+7.3%)
Sep 2018
-
-$41.52 M(+11.1%)
-$144.59 M(+14.8%)
Jun 2018
-
-$37.38 M(+5.3%)
-$125.94 M(+18.4%)
Mar 2018
-
-$35.48 M(+17.4%)
-$106.32 M(+8.7%)
Dec 2017
-$97.77 M(-16.0%)
-$30.21 M(+32.1%)
-$97.77 M(+2.9%)
Sep 2017
-
-$22.87 M(+28.8%)
-$95.05 M(-7.2%)
Jun 2017
-
-$17.76 M(-34.1%)
-$102.44 M(-11.3%)
Mar 2017
-
-$26.93 M(-2.0%)
-$115.52 M(-0.8%)
Dec 2016
-$116.43 M(+11.1%)
-$27.48 M(-9.2%)
-$116.43 M(-1.1%)
Sep 2016
-
-$30.27 M(-1.8%)
-$117.78 M(-1.6%)
Jun 2016
-
-$30.83 M(+10.8%)
-$119.67 M(+8.4%)
Mar 2016
-
-$27.84 M(-3.4%)
-$110.35 M(+5.3%)
Dec 2015
-$104.79 M(+241.4%)
-$28.83 M(-10.3%)
-$104.79 M(+15.0%)
Sep 2015
-
-$32.16 M(+49.5%)
-$91.16 M(+39.4%)
Jun 2015
-
-$21.51 M(-3.5%)
-$65.41 M(+35.1%)
Mar 2015
-
-$22.29 M(+46.6%)
-$48.43 M(+57.8%)
Dec 2014
-$30.69 M(+14.2%)
-$15.20 M(+136.9%)
-$30.69 M(+30.4%)
Sep 2014
-
-$6.42 M(+41.5%)
-$23.53 M(+6.8%)
Jun 2014
-
-$4.53 M(-0.2%)
-$22.03 M(+25.8%)
Mar 2014
-
-$4.54 M(-43.5%)
-$17.51 M(+35.0%)
Dec 2013
-$26.87 M(+61.9%)
-$8.04 M(+63.7%)
-$12.96 M(+163.3%)
Sep 2013
-
-$4.91 M(>+9900.0%)
-$4.92 M(>+9900.0%)
Jun 2013
-
-$10.90 K
-$10.90 K
Dec 2012
-$16.59 M
-
-

FAQ

  • What is Intra-Cellular Therapies annual net profit?
  • What is the all time high annual net income for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies annual net income year-on-year change?
  • What is Intra-Cellular Therapies quarterly net profit?
  • What is the all time high quarterly net income for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies quarterly net income year-on-year change?
  • What is Intra-Cellular Therapies TTM net profit?
  • What is the all time high TTM net income for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies TTM net income year-on-year change?

What is Intra-Cellular Therapies annual net profit?

The current annual net income of ITCI is -$74.68 M

What is the all time high annual net income for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high annual net profit is -$16.59 M

What is Intra-Cellular Therapies annual net income year-on-year change?

Over the past year, ITCI annual net profit has changed by +$65.00 M (+46.54%)

What is Intra-Cellular Therapies quarterly net profit?

The current quarterly net income of ITCI is -$16.89 M

What is the all time high quarterly net income for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high quarterly net profit is -$10.90 K

What is Intra-Cellular Therapies quarterly net income year-on-year change?

Over the past year, ITCI quarterly net profit has changed by +$9.44 M (+35.86%)

What is Intra-Cellular Therapies TTM net profit?

The current TTM net income of ITCI is -$74.68 M

What is the all time high TTM net income for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high TTM net profit is -$10.90 K

What is Intra-Cellular Therapies TTM net income year-on-year change?

Over the past year, ITCI TTM net profit has changed by +$11.69 M (+13.54%)